IP Library Granted Patent US 7,153,831
Granted Patent B2
US 7,153,831 · App. 11/257,883 · Granted Dec 26, 2006

Rabconnectin-3-binding protein

Assignee: Eisai Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,153,831
App. No.
11/257,883
Granted
Dec 26, 2006
Kind
B2
Abstract

A protein useful for clarifying the regulation mechanism of Ca 2+ -dependent exocytosis in particular, the activation and inactivation of Rab3A, and a method of screening for a material useful for regulating Ca 2+ -dependent exocytosis in particular, the activation and inactivation of Rab3A, using the above protein. By using the coimmunoprecipitation with an anti-Rab3A GEP antibody, a protein participated in the regulation of activation or inactivation of Rab3A is determined. As the protein binds to rabconnectin-3 and GDP/GTP exchange protein, it can be used for screening for a material that increases or decreases the binding.

Claims (7)

1. A method of screening for a material that promotes or inhibits binding between a rabconnectin-3-binding protein and rabconnectin-3, comprising the steps of:

contacting a rabconnectin-3-binding protein with rabconnectin-3 in the presence and absence of a candidate material, and

determining whether the candidate material increases or decreases binding between the rabconnectin-3-binding protein and rabconnectin-3, wherein the rabconnectin-3-binding protein is a protein comprising the amino acid sequence of SEQ ID NO: 2.

2. The method of claim 1 , wherein the amino acid sequence of the rabconnectin-3-binding protein consists of the amino acid sequence of SEQ ID NO: 2.

3. A method of screening for a material that promotes or inhibits binding between a rabconnectin-3-binding protein and rabconnectin-3, comprising the steps of: contacting a rabconnectin-3-binding protein with rabconnectin-3 in the presence and absence of a candidate material, and

determining whether the candidate material increases or decreases binding between the rabconnectin-3 -binding protein and rabconnectin-3, wherein the rabconnectin-3-binding protein is a protein comprising the amino acid sequence of SEQ ID NO: 2 with one to thirty amino acids deleted, replaced, or added, and having an activity of binding rabconnectin-3 and a GDP/GTP exchange protein.

4. The method of claim 3 , wherein the rabconnectin-3-binding protein is obtained by subjecting the DNA encoding the protein comprising the amino acid sequence of SEQ ID NO: 2 to mutagenesis and selecting for a DNA encoding a mutant protein having an activity of binding rabconnectin-3 and a GDP/GTP exchange protein.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2007
From: EISAI CO., LTD.
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 019235/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2005
From: TAKEUCHI, MASAKAZU; TAKAI, YOSHIMI
To: EISAI CO., LTD.
Reel/Frame 017149/0692 →
Priority Claims (1)
JP 2002-319521 · Nov 1, 2002 · national
Continuity (2)
Division 1064533500 · Aug 21, 2003
Related Publication 20060040328A1 · Feb 23, 2006